The remainder (about 10%) are mostly IDH-mutant tumors, typically arising from lower grade infiltrating astrocytomas, and thus clinically referred to as secondary glioblastoma. The gene discussed is IDH1; the disease is astrocytoma (excluding glioblastoma).